TRIMURTHI LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.04 INR | 0.00% |
|
0.00% | +60.36% |
| Sales 2022 | 89.13M 1.07M 1.46M | Sales 2023 | 19.2M 231K 316K | Capitalization | 72.9M 876K 1.2M |
|---|---|---|---|---|---|
| Net income 2022 | -20M -240K -329K | Net income 2023 | - 0 0 | EV / Sales 2022 | 0.49 x |
| Net cash position 2022 | 28.44M 342K 467K | Net cash position 2023 | 31.66M 380K 520K | EV / Sales 2023 | 2.15 x |
| P/E ratio 2022 |
-3.55
x | P/E ratio 2023 |
-122
x | Employees | 7 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 19.13% |
More Fundamentals
* Assessed data
More news
| Current month | +4.94% | ||
| 1 month | +4.94% | ||
| 3 months | +47.39% | ||
| 6 months | +71.81% | ||
| Current year | +60.36% |
1 week
18.04
18.04
1 month
17.1918.04
Current year
8.1018.04
1 year
8.0018.04
3 years
5.3818.04
5 years
1.8518.04
10 years
1.8518.04
| Managers | Title | Age | Since |
|---|---|---|---|
Ravi Bhangadia
CEO | Chief Executive Officer | - | 23-08-08 |
Vani Manda
DFI | Director of Finance/CFO | - | 14-09-03 |
Nishita Kalantri
CMP | Compliance Officer | - | 19-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 49 | 05-05-03 | |
| Director/Board Member | 43 | 17-02-12 | |
| Director/Board Member | 34 | 16-06-06 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-27 | 18.04 | 0.00% | 9,410 |
Delayed Quote Bombay S.E., May 27, 2024 at 06:00 am
More quotes
Trimurthi Limited is an India-based holding company. The Company is engaged in pharmaceutical distribution and retail pharmacy. The Companyâs segments include Pharma Business, Financial Services, Investments, Foods and Trading in Shares. The Companyâs services include distribution network for pharmaceutical products, retail pharmacy and marketing. Its products include ULCIZOL, OXYMIN, Volivia Gold, Conplus, Oriflox, Treb-DSR, ACLO-P, LAMITAB and others. The Company has its pharmacy retail Outlet in Himayath Nagar, Hyderabad and Inderbagh, Sultan Bazar, Hyderabad. It has its operations in the state of West Bengal and has its presence in the Eastern part of India. Trimurthi Pharmaceuticals (India) Private Limited is the Companyâs subsidiary.
Calendar
2024-08-06
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +60.36% | 1.75M | |
| +3.76% | 158B | |
| +16.36% | 155B | |
| +3.30% | 129B | |
| +20.22% | 118B | |
| -8.44% | 35.55B | |
| +9.77% | 25.23B | |
| +22.71% | 20.91B | |
| -7.68% | 20.05B | |
| +42.62% | 17.56B |
- Stock Market
- Equities
- 536565 Stock
